Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles — A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution-Reference-Cited by-同舟云学术

Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles — A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution

Published:2018-06 Issue: Volume:112 Page:818-830
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Mandal Dipika,Shaw Tapan Kumar^ORCID,Dey Goutam,Pal Murari Mohan,Mukherjee Biswajit^ORCID,Bandyopadhyay Amal Kumar,Mandal Mahitosh

Funder

University Grants Commission

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference68 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2018

2. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

3. Primary liver cancer: worldwide incidence and trends;Bosch;Gastroenterologia,2004

4. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells;Mukesh;Colloids Surf., B.,2016

5. Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy;Ryu;Adv. Drug Deliv. Rev.,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-house glutamine based compound loaded poly-(D-L-lactide-coglycolide) nanoparticles as a possible candidate for the management of chronic myeloid leukemia;Materials Today: Proceedings;2023-11

2. New Era on Combining Both Imaging and Drug Delivery to Treat Cancer;Current Pharmaceutical Biotechnology;2023-06

3. Synthesis, Characterization, and Biological Evaluation of Radiolabeled Glutamine Conjugated Polymeric Nanoparticles: A Simple Approach for Tumor Imaging;ACS Applied Bio Materials;2023-05-29

4. Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer;Journal of Drug Targeting;2023-04-14

5. Assessment of superiority of HSP70-targeting aptamer-functionalized drug-nanocarrier over non-targeted commercially available counterpart in HCC therapy: in vitro and in vivo investigations and molecular modeling;Life Sciences;2023-03